title: [Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine].
abstract: The bile acid sequestering agent Vasosan P is a new form of pectin-enriched cholestyramine (20%), saccharose (5%) and sorbic acid (0.18%). In comparison with cholestyramine Vasosan P has a more marked hypolipidemic effect in experiment. Vasosan P is remarkable for good organoleptic properties. It is effective in treating patients with type IIa hyperlipoproteinemia and practically has no side effects as cholestyramine.
authors: V E
authors: VE
authors: Ryzhenkov
authors: A M
authors: AM
authors: Chistiakova
authors: V F
authors: VF
authors: Triufanov
authors: L E
authors: LE
authors: Vasil'eva
authors: Iu V
authors: IuV
authors: Frolova
authors: M A
authors: MA
authors: Solov'eva
authors: O V
authors: OV
authors: Remezova
authors: V T
authors: VT
authors: Lozovskiĭ
authors: M
authors: M
authors: Khanefel'd
authors: V
authors: V
authors: Leonkhardt
mesh_terms: D000818:Animals; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use*; D006168:Guinea Pigs; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008099:Liver / Q000378:metabolism; D051381:Rats; D014280:Triglycerides / Q000097:blood
chemical_list: D008055:Lipids; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol
vernacular_title: Eksperimental'noe i klinicheskoe izuchenie vasozana P--novoĭ formy kholestiramina, obogashchennogo pektinom.